Trial Profile
A Multicenter, Double-Blind, Double-Dummy, Randomized Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures With or Without Secondary Generalization.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 May 2023
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary) ; Lacosamide
- Indications Partial epilepsies
- Focus Adverse reactions
- Sponsors UCB
- 04 Dec 2008 New trial record.